Related Experiment Video
Updated: Aug 13, 2026
09:09
Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
Published on: April 20, 2018
Macrophages and the pathogenesis of COPD
1National Heart & Lung Institute, Imperial College, London SW3 6LY, UK. t.tetley@ic.ac.uk
Chest
|May 16, 2002
Summary
Macrophages in the lungs, crucial for clearing dead cells, may drive COPD. Increased numbers and proteinase release by these cells contribute to lung tissue damage in smokers with COPD.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pathology
Background:
- Macrophages are key lung effector cells, responding to stimuli and clearing apoptotic neutrophils.
- Their function is implicated in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis.
- Increased proteinase burden is linked to tissue destruction in COPD.
Purpose of the Study:
- To investigate the significant role of macrophages in COPD.
- To understand the contribution of macrophage-derived proteinases to lung tissue destruction.
Main Methods:
- Comparative analysis of cell types and matrix metalloproteinase (MMP) levels in lung tissue from COPD and control subjects.
- Assessment of macrophage numbers and their proteinase release in the context of COPD.
Main Results:
- While epithelial cells and fibroblasts show increased MMPs, macrophages exhibit a 5- to 10-fold numerical increase in COPD lungs.
- Co-release of MMPs and other proteinases by these increased macrophages elevates proteinase potential in small airways.
- This macrophage-driven process likely contributes to tissue destruction and inflammation in COPD.
Conclusions:
- Macrophages play a highly significant role in COPD pathology due to increased numbers and elevated proteinase activity.
- The findings suggest that macrophage-mediated tissue destruction is a key driver of COPD.
- In smokers without COPD, tightly controlled inflammatory processes or effective lung repair mechanisms may be present.
More Related Videos
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...